Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings

Clinical and Vaccine Immunology

Volumn 19, Issue 11, 2012, Pages 1810-1817

  Mercader, Sara ^a   Garcia, Philip ^a   Bellini, William J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLAMINE; IMMUNOGLOBULIN G; MEASLES VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PH; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; VACCINE FAILURE; VALIDATION STUDY;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; DISEASE ERADICATION; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TIME FACTORS; TREATMENT FAILURE;

EID: 84868249031     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00406-12     Document Type: Article

References (44)

1. Afzal MA, et al. 1998. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. J. Med. Virol. 55:243-249. (Pubitemid 28270771)
2. Atrasheuskaya AV, et al. 2005. Measles in Minsk, Belarus, 2001-2003: clinical, virological and serological parameters. J. Clin. Virol. 34:179-185. (Pubitemid 41427313)
3. Atrasheuskaya AV, Kulak MV, Neverov AA, Rubin S, Ignatyev GM. 2008. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005. Vaccine 26:2111-2118.
4. Bellini WJ, Helfand RF. 2003. The challenges and strategies for laboratory diagnosis of measles in an international setting. J. Infect. Dis. 187(Suppl. 1):S283-S290. (Pubitemid 36583968)
5. Böttiger B, Jensen IP. 1997. Maturation of rubella IgG avidity over time after acute rubella infection. Clin. Diagn. Virol. 8:105-111. (Pubitemid 27397834)
6. Brunell PA, et al. 1995. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:540-548.
7. CDC. 2012. Measles-United States, 2011. MMWRMorb. Mortal. Wkly. Rep. 61:253-257.
8. CDC. 2011. Notes from the field: measles outbreak-Hennepin County, Minnesota, February-March 2011. MMWR Morb. Mortal. Wkly. Rep. 60:421.
9. CDC. 2011. Notes from the field: measles outbreak-Indiana, June-July 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1169.
10. CLSI. 2004. Evaluation of precision performance of quantitative measurement methods: approved guideline-2nd ed. CLSI document EP5-A2. CLSI, Wayne, PA.
11. Dietz V, Rota J, Izurieta H, Carrasco P, Bellini W. 2004. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull. World Health Organ. 82:852-857. (Pubitemid 39573743)
12. Edmonson MB, et al. 1990. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467-2471. (Pubitemid 20169459)
13. Eisen H, Siskind G. 1964. Variation in affinities of antibodies during immune response. Biochemistry 3:996.
14. El Mubarak HS, et al. 2004. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J. Med. Virol. 72:290-298. (Pubitemid 38020558)
15. Greiner M, Pfeiffer D, Smith RD. 2000. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 45:23-41. (Pubitemid 30308338)
16. Hamkar R, et al. 2006. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. East Mediterr. Health J. 12:775-782. (Pubitemid 46358272)
17. Hanley JA, McNeil BJ. 1982. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36. (Pubitemid 12142173)
18. Hedman K, Lappalainen M, Söderlund M, Hedman L. 1993. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:123-129. (Pubitemid 23225569)
19. Hickman C, et al. 2011. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J. Infect. Dis. 204(Suppl. 1):S549-S558.
20. Hummel KB, Erdman DD, Heath J, Bellini WJ. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:2874-2880.
21. Hyde TB, et al. 2009. Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003. Bull. World Health Organ. 87:93-98.
22. Jenum PA, Stray-Pedersen B, Gundersen AG. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J. Clin. Microbiol. 35:1972-1977. (Pubitemid 27318688)
23. Kuby J. 1997. Immunology, 3rd ed. W. H. Freeman, New York, NY.
24. Kutty P, Rota J, Bellini W, Redd SB. 17 April 2012, posting date. Chapter 7, Measles. In Manual for the Surveillance of Vaccine-Preventable Diseases, 5th ed. CDC, Atlanta, GA. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt07- measles.html.
25. Lappalainen M, Hedman K. 2004. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann. Ist Super Sanita 40:81-88. (Pubitemid 39310675)
26. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. 2008. New advances in the diagnosis of congenital cytomegalovirus infection. J. Clin. Virol. 41:192.
27. Nair N, et al. 2007. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J. Infect. Dis. 196:1339-1345. (Pubitemid 351412006)
28. Nair N, et al. 2009. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J. Infect. Dis. 200:1031-1038.
29. Obuchowski NA, Lieber ML, and Wians FH, Jr. 2004. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin. Chem. 50: 1118-1125. (Pubitemid 38824221)
30. Orenstein WA, Papania MJ, Wharton ME. 2004. Measles elimination in the United States. J. Infect. Dis. 189(Suppl. 1):S1-S3. (Pubitemid 38639561)
31. Pannuti CS, et al. 2004. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin. Diagn. Lab. Immunol. 11:119-122. (Pubitemid 38090664)
32. Paunio M, Hedman K, Davidkin I, Peltola H. 2003. IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy. Expert Opin. Pharmacother. 4:1215-1225. (Pubitemid 36949672)
33. Paunio M, et al. 2000. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol. Infect. 124:263-271. (Pubitemid 30224135)
34. Rota J, et al. 2011. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J. Infect. Dis. 204(Suppl. 1):S559-S563.
35. Siskind GW, Benacerraf B. 1969. Cell selection by antigen in the immune response. Adv. Immunol. 10:1.
36. Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P. 1999. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J. Clin. Virol. 14:107-118. (Pubitemid 29512207)
37. Tuokko H. 1995. Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulinGantibody avidity enzyme immunoassay. J. Med. Virol. 45:306-311.
38. Vardas E, Kreis S. 1999. Isolation of measles virus from a naturallyimmune, asymptomatically re-infected individual. J. Clin. Virol. 13:173-179. (Pubitemid 29349105)
39. Ward KN. 2005. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J. Clin. Virol. 32:183-193. (Pubitemid 40255086)
40. Wei X, et al. 2010. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res. Hum. Retrovir. 26:61-71.
41. WHO. 2007. Manual for the laboratory diagnosis of measles and rubella virus infection, 2nd ed. http://www.who.int/immunization-monitoring/ LabManualFinal.pdf. Accessed 23 May 2012.
42. Williams RL. 2008. Taylor series linearization. In Lavrakas PJ (ed), Encyclopedia of survey research methods. Sage Publications, Inc., Thousand Oaks, CA.
43. Zhou X-H, Obuchowski NA, McClish DK. 2002. Statistical methods in diagnostic medicine. Wiley-Interscience, New York, NY.
44. Zweig MH, Campbell G. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577. (Pubitemid 23118304)